FDA Approval for AI Devices – Key Insights (2019–2023)

FDA approval for AI devices has increased dramatically as artificial intelligence and machine learning transform healthcare. The steady rise in FDA approval for AI devices reflects growing regulatory trust and wider adoption across medical specialties.

Between 2019 and 2023, FDA approval for AI devices grew from 80 devices in 2019 to 221 devices in 2023, reaching a total of 702 approved AI/ML-enabled medical devices. This sharp growth highlights the expanding role of AI in diagnostics, imaging, and clinical decision support.

Radiology leads in FDA approval for AI devices, accounting for the majority of approvals, followed by Cardiovascular and Neurology devices. Emerging fields like Pathology and Gastroenterology-Urology are also adopting AI-based solutions.

Overall, the surge in FDA approval for AI devices signals a major shift toward precision medicine, faster diagnosis, and technology-driven patient care, positioning AI as a core component of the future of healthcare.